Balasa Dinverno & Foltz LLC Eli Lilly & CO Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 15,259 shares of LLY stock, worth $12.1 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

15,259

Previous 15,877 3.89%

Holding current value

$12.1 Million

Previous $5.15 Million 4.16%

% of portfolio

0.31%

Previous 0.32%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $183,224 - $208,803	-618 Reduced 3.89%	15,259 $4.93 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $640,521 - $752,066	2,298 Added 16.92%	15,877 $5.15 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $48,346 - $60,081	-206 Reduced 1.49%	13,579 $3.89 Million
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $179,655 - $222,952	-799 Reduced 5.48%	13,785 $3.81 Million
Q3 2021 Oct 26, 2021	BUY	$221.6 - $272.71 $273,232 - $336,251	1,233 Added 9.24%	14,584 $3.37 Million
Q2 2021 Jul 23, 2021	BUY	$180.55 - $233.54 $2.41 Million - $3.12 Million	13,351 New	13,351 $3.06 Million
Q4 2020 Jan 26, 2021	SELL	$130.46 - $172.63 $1.66 Million - $2.2 Million	-12,719 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $541,745 - $626,626	-3,705 Reduced 22.56%	12,719 $1.88 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $63,708 - $76,672	-467 Reduced 2.76%	16,424 $2.7 Million
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $1.43 Million - $1.77 Million	11,996 Added 245.07%	16,891 $2.34 Million
Q4 2019 Jan 22, 2020	SELL	$106.92 - $132.43 $46,830 - $58,004	-438 Reduced 8.21%	4,895 $643,000
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $183,465 - $199,562	-1,718 Reduced 24.37%	5,333 $596,000
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $111,565 - $130,225	-1,007 Reduced 12.5%	7,051 $781,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $237,424 - $279,465	2,133 Added 36.0%	8,058 $1.05 Million
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $243,146 - $272,397	2,296 Added 63.27%	5,925 $686,000
Q3 2018 Oct 24, 2018	BUY	$85.86 - $107.31 $42,844 - $53,547	499 Added 15.94%	3,629 $389,000
Q2 2018 Aug 01, 2018	BUY	$75.7 - $86.88 $4,920 - $5,647	65 Added 2.12%	3,130 $267,000
Q1 2018 Apr 23, 2018	SELL	$74.21 - $87.6 $27,309 - $32,236	-368 Reduced 10.72%	3,065 $237,000
Q4 2017 Feb 05, 2018	BUY	$81.94 - $87.89 $3,605 - $3,867	44 Added 1.3%	3,433 $290,000
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $261,190 - $289,895	3,389	3,389 $290,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Eli Lilly & CO Transaction History